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Abstract
Background: Choosing trial outcome measures is important. When outcomes are not clinically relevant or important to
parents/patients, trial evidence is less likely to be implemented into practice. This study aimed to determine optimal outcome
measures for a trial of no routine gastric residual volume (GRV) measurement in critically ill children.Methods:Amixed-methods
approach was used: a focused literature review, parent and clinician interviews, a modified 2-round Delphi, and a stakeholder
consensus meeting. Results: The review generated 13 outcomes. Fourteen pediatric intensive care unit (PICU) parents proposed
3 additional outcomes; these 16 were then rated by 28 clinicians in Delphi round 1. Six further outcomes were proposed, and
22 outcomes were rated in the second round. No items were voted “consensus out.” The 18 “no-consensus” items were voted in
a face-to-face meeting by 30 participants. The final 12 outcome measures were time to reach energy targets, ventilator-associated
pneumonia, vomiting, time enteral feeds withheld per 24 hours, necrotizing enterocolitis, length of invasive ventilation, PICU length
of stay, mortality, change in weight and markers of feed intolerance (parenteral nutrition administered), feed formula altered, and
change to postpyloric feeds all secondary to feed intolerance. Conclusion: We have identified 12 outcomes for a trial of no GRV
measurement through a multistage process, seeking views of parents and clinicians. (JPEN J Parenter Enteral Nutr. 2020;00:1–8)
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Clinical Relevancy Statement
Twelve relevant outcomes have been identified for a trial of
no routine gastric residual volumemeasurement in critically
ill children.
Introduction
Selecting the most appropriate outcome measures for a trial
is increasingly recognized as important for trial evidence to
be effectively implemented into clinical practice.1 Ensuring
trial outcomes are both clinically relevant and important
to parents and patients is vital to optimize the impact of
the research and to improve implementation and uptake
into practice.2 In addition, heterogeneity of clinical trial
outcomes is a problem across clinical medicine but is more
pronounced in relatively “small”specialties such as pediatric
critical care, in which many trials are single centered3 and
underpowered. In such “small” specialties, synthesis of
trial results is essential for evidence-based practice, but
unfortunately, the pooling of trial results in meta-analyses
is often not possible because of outcome heterogeneity. This
work, as part of a larger funded feasibility study, sought
to determine the optimal parent and clinician outcome
measures for a future trial of no routine gastric residual
volume (GRV) measurement to guide enteral feeding in pe-
diatric critical care. The proposed future trial of no routine
GRVmeasurement (compared with standard care involving
regular GRV measurement) to guide enteral feeding in crit-
ically ill children was called the GASTRIC trial.4 This was
a National Institute for Health Research (NIHR)–funded
mixed-methods feasibility study to determine whether it was
possible to conduct a future trial in UK pediatric intensive
care units (PICUs).
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Methods
A mixed-methods study was undertaken between March
2018 and April 2019 as part of a larger NIHR Health
Technology Assessment (HTA)–funded study (GASTRIC
Reference16/94/02). The trial was registered on the ISRCTN
registry (42110505). There were 4 phases involved in identi-
fying the optimal outcomes:
1. A focused literature review to identify outcomes
used in previous clinical trials and observational
studies of GRV in any critically ill populations:
including adults and preterm neonates. Databases
were searched (Medline, CINAHL, ProQuest) in
March 2018 by L.N.T. using the search terms: "gas-
tric residual" and "gastric aspirate" in critically ill
patients. For included studies, detailed data on each
outcome measure used were extracted into a data
collection form for summarizing.
2. Parent interviews: Qualitative researchers (L.R. and
E.D.) recruited parents with experience of tube
feeding in PICUs in the last 3 years though 4 routes.
These included the use of social media, national
contacts, word of mouth, and newspaper advertise-
ments. Parents were excluded if they did not speak
English. Once eligibility was confirmed, an inter-
view date and time were scheduled. A participant
information sheet, with a list of potential outcomes
developed from the focused literature review, was
emailed to parents to read prior to the interview.
Based on previous research, it was anticipated that
10–15 parents would be recruited to reach data
saturation point.5 This is when the major themes
identified in new data are recurring from previous
interviews and no new major themes are being
discovered in analysis.6 Interviews explored views on
the proposedGASTRIC trial. The last section of the
interview included a series of questions to determine
what outcomes parents felt would be important
to measure in the proposed trial and then asked
parents to rank them by importance. Full details
of the outcome prioritization process are reported
in a previous study conducted by members of our
team.7 Content analysis8 was then used to identify
outcomes to inform the subsequent Delphi study.
3. Delphi study: A modified 2-round Delphi method
was used,9 and an e-survey was developed (Supple-
mentary File S1), derived from information gained
from the literature review and the parent interviews.
The survey was pilot-tested for clarity and face
validity with 10 individuals (a mix of nurses, doc-
tors, and dietitians) and then tested again within
the study team. It was then input into Delphi-
Manager Software.10 Key healthcare professional
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stakeholder groups were identified as UK-based,
research-engaged PICU nurses, PICU doctors, pe-
diatric surgeons, and PICU dietitians. Participants
were invited to take part via email, through their
professional networks (British Dietetic Association
[BDA], Pediatric Intensive Care Society [PICS], and
its associated study group PICS-SG). The target
number of respondents was 40, and automated re-
minders were sent weekly via the survey software.
Participants were allocated a unique identifier to
allow identification of individuals completing all
rounds of the Delphi exercise.
Round 1 of the survey consisted of a succinct
summary of the review findings by way of an intro-
duction (previously used trial designs and primary
and secondary outcomes), a question to establish
respondents’ stakeholder group, and a set of out-
comes to score (Supplementary File S1). Participants
were invited to score the importance of each of
the outcomes listed using a 9-point Likert scale
as recommended by the Grading of Recommen-
dations Assessment, Development and Evaluation
(GRADE) working group,11 with 1–3 labeled "not
important," 4–6 labeled "important but not critical,"
and 7–9 labeled "critical." Participants were able to
provide comment on outcomes and were asked to
suggest any additional outcomes that they thought
were relevant (Supplementary File S1). Outcomes
were listed alphabetically to avoid potential weight-
ing of outcomes caused by the order in which they
were displayed. For each outcome, the number of
participants who scored the outcome and the dis-
tribution of scores (percentages of who had scored
each outcome) were summarized by stakeholder
group. At the end of round 1, the study management
group reviewed the suggested additional outcomes
and identified new distinct outcomes to add to the
next round. In round 2, participants were presented
with a summary of the results of round 1 (histograms
of scores for each outcome and each stakeholder
group) and asked to rescore these outcomes. They
were also asked to score any additional outcomes
suggested in round 1. Finally, they were asked to
specify a single primary outcome.
Outcome scores for each round were summarized
using descriptive statistics and histograms, split by
stakeholder group. Free text responses were listed.
The round 2 scores were used to formulate con-
sensus statistics for each outcome by stakeholder
group and, overall, the percentage of respondents
that scored 7, 8, or 9 (outcome rated critical); the
percentage that score it 1, 2, or 3 (outcome rated
unimportant); and consensus status ("consensus in,"
"consensus out," "no consensus") (Table 1).
Table 1. Definition of Consensus Status.
Consensus
status Description Definition
Consensus in Consensus that the
outcome should
be included in a
future study
design
70% or more
participants
scoring as 7–9
AND <15% of
participants
scoring as 1–3 in
each group
Consensus out Consensus that the
outcome should
not be included
in the future
study design
70% or more
participants
scoring as 1–3
AND <15% of
participants
scoring as 7–9 in
each group
No consensus Uncertainty about
the outcome
Anything else
4. Face-to-face consensus meeting: The aims of this
meeting were to review the results of the mixed-
methods study, vote on outcomes that did not reach
consensus in the Delphi survey, and discuss future
trial feasibility and design. Parents were invited to
this meeting along with PICU healthcare profession-
als from all the UK PICUs. A skilled and indepen-
dent facilitator led this meeting with the involvement
of the study team. Voting results were summarized
using the same methodology as described for the
Delphi. Ethical approval was obtained from the
University of the West of England in April 2018
(REF HAS.18.04.144).
Results
Literature Review
A focused review of the literature to identify previous trials
and studies around GRV measurement in all critically ill
populationswas undertaken inMarch 2018. Six studies were
identified that studied GRV, 1 in the pediatric population,12
3 in critically ill adults,13-15 and 2 in critically ill preterm
neonates.16,17 All the outcomes reported in these studies
have been summarized into 14 outcomes (Table 2). Two
of these outcomes (days receiving parenteral nutrition and
days of central venous line access) were relevant only for
preterm infants and thus removed, and others (gastrointesti-
nal morbidity) were separated into vomiting and diarrhea as
separate outcomes, generating 13 items from the literature
review.
Figure 1 shows the flowchart detailing the generation of
outcomes across all stages of the study.
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Table 2. Outcomes Identified in Previous Studies of GRV
Measurement.
Outcome Patient
population
1. Intensive care unit length of stay All
2. Hospital length of stay All
3. Length of invasive ventilation All
4. Occurrence of ventilator-associated
pneumonia
Adult and
pediatric
5. Achievement of predicted energy goals
using various definitions:
Proportion of patients achieving 100%
Cumulative energy deficit over 7 days
Ratio of prescribed/achieved energy
target
Enteral feeding "adequacy"
Median daily volume of feed given
Percentage of predicted energy
requirement achieved per day
Time to achieve full feeds for preterm
neonates (120 mL/kg and
150 mL/kg/d)
Adult,
pediatric,
and neonatal
6. Occurrence of necrotizing enterocolitis Neonatal and
pediatric
7. Incidence of GI intolerance: vomiting,
diarrhea, abdominal distention, feed
intolerance, gastroesophageal reflux
Adult and
pediatric
8. Nursing time spent measuring GRV Adult
9. Growth (weight) from admission to
discharge
Neonatal and
pediatric
10. Growth (length) from admission to
discharge
Neonatal
11. Days of PN Neonatal
12. Days of central venous catheter (to
deliver PN)
Neonatal
13. Time spent receiving nothing by mouth
(no enteral feed) in 24-hour period
Adult
14. Survival All
GI, gastrointestinal; GRV, gastric residual volume; PN, parenteral
nutrition.
Parent-Important Outcomes
Fourteen PICU parents were interviewed regarding 10 chil-
dren (4 sets of parents were interviewed separately about
their child), and 6 out of 10 children had had a previous
neonatal unit admission. Interviews took place an average
of 11 months (range, 8–37 months) after PICU admission.
The children’s cause of PICU admission varied: congenital
heart disease (n = 4), sepsis (n = 2), airway (n = 1),
and complications of congenital conditions (n = 3). The
parents proposed 7 outcomes of importance; 4 of these were
duplicate items generated from the literature review. The
3 nonduplicate parent-reported outcomes were long-term
feeding issues, being "back to their normal self," and longer-
term outcomes (after hospital discharge).
Figure 1. Study flowchart indicating how final outcomes were
obtained.
Delphi Study
A total of 16 outcomes were included in round 1 of the
Delphi. In November 2018, 45 PICU healthcare profes-
sionals were invited to take part in the Delphi survey. Of
these, 30/45 (67%) registered for the survey, 28/45 (61%)
went on to score the 16 outcomes in round 1, and of these,
22/28 (79%) went on to complete round 2. Six distinct
outcomeswere suggested by respondents in round 1,making
22 outcomes to be scored in round 2. Sixty-four percent
(14/22) of respondents changed their score for at least 3
outcomes from round 1 to round 2. "Consensus in" was
achieved on only 4 outcomes by all 3 professional groups:
incidence of gastrointestinal morbidity (vomiting); inci-
dence of ventilator-acquired pneumonia (VAP); duration
of time with no enteral feed per 24-hour period; and the
time to achievement of estimated energy requirements. All
outcomes scored in round 2 are shown in Table 3, together
with the source of the outcome and consensus status. No
outcomes were voted "consensus out." Respondents were
asked their choice of primary outcome measure for a future
trial, and 8/22 (36%) preferred time to achievement of
energy targets, with 5/22 (23%) choosing incidence of VAP.
Consensus Meeting
Twenty-six PICU healthcare professionals (4 dietitians, 9
physicians, 12 nurses, and 1 general surgeon) attended the
consensus meeting on April 2, 2019; some of these had
Tume et al 5
Table 3. Percentage of Participants That Scored 7, 8, or 9 for Each Outcome Scored in Round 2 of the Delphi Study, by
Stakeholder Group.
Outcome
Source
of
outcome
PICU
doctors
and
pediatric
general
surgeon
(n = 11)
PICU
nurses
(n = 8)
PICU
dietitians
(n = 3)
All
(n = 22)
Consensus
status
Time to achievement of predicted
energy goals
LR 90.9%a a87.5%a a100%a 90.9%a In
Incidence of ventilator-acquired
pneumonia
LR a81.8%a a87.5%a a100%a 86.4%a In
Time feed stopped per 24 hours LR a81.8%a a87.5%a a100%a 86.4%a In
Incidence of necrotizing enterocolitis DR1 a90.9%a a87.5%a 66.7% a86.4%a None
Incidence of GI morbidity: Vomiting LR a72.7%a a87.5%a a100%a 81.8%a In
Length of time IV LR 63.6% a75%a a100%a a72.7%a None
Mortality LR 63.6% 62.5% a100%a 68.2% None
Length of stay: PICU LR 63.6% 62.5% 66.7% 63.6% None
Total length of time respiratory
support (IV + NIV)
LR 63.6% 50% a100%a 63.6% None
Nursing time spent measuring GRV LR 54.5% 50% a100%a 59.1% None
Length of stay: Hospital LR 63.6% 37.5% 66.7% 54.5% None
Administration of parenteral
nutrition secondary to feed
intolerance
DR1 45.5% 37.5% 66.7% 45.5% None
PP feeding (placing a PP tube)
secondary to feed intolerance
DR1 27.3% 50% a100%a 45.5% None
Change in weight (growth) between
PICU admission and discharge
LR 27.3% 50% 66.7% 40.9% None
Long-term feeding issues Parents 27.3% 37.5% 33.3% 31.8% None
GI morbidity: Diarrhea LR 9.1% 37.5% 66.7% 27.3% None
Long-term outcomes (after hospital
discharge)
Parents 36.4% 25% 0% 27.3% None
Administration of prokinetic drugs
secondary to feed intolerance
DR1 18.2% 12.5% 66.7% 22.7% None
Looking and/or behaving like their
normal self
Parents 18.2% 25% 0% 18.2% None
Change in length (growth) between
PICU admission and discharge
LR 18.2% 12.5% 33.3% 18.2% None
Change to feed formula type
secondary to feed intolerance
DR1 0% 25% 66.7% 18.2% None
Parental satisfaction DR1 9.1% 0% 33.3% 9.1% None
DR1, Delphi round 1; GI, gastrointestinal; GRV, gastric residual volume; IV, invasive ventilation; LR, literature review; NIV, noninvasive
ventilation; PICU, pediatric intensive care unit; PP, postpyloric.
a“Consensus in” criteria were met: ≥70% scored 7, 8, or 9 and <15% scored 1, 2, or 3.
b“Consensus in” criteria met in all groups.
participated in the Delphi study. Despite 2 parents agreeing
to participate, no parents were able to attend on the day.
The professionals represented 13 different UK PICUs out
of a possible 27. At this meeting, there was discussion
and subsequent voting on the 18 outcomes that did not
reach consensus in the Delphi study. Using the same scoring
criteria as the Delphi survey, 8 items were voted "consensus
in," 6 were voted "consensus out," and 4 failed to reach any
consensus (Table 4). The choice of the 2 primary outcome
measures, time to achieve estimated energy requirements
and VAP, was presented and their feasibility discussed, but
no voting took place on these. The final list of the 12
consensus outcomes for a future trial is presented in Table 5.
Discussion
This is one of the few studies in pediatric critical care to use a
robust process to identify outcomes of importance for both
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Table 4. No-Consensus Items Voted on at Consensus Meeting.
Outcome Consensus Status
Administration of parenteral nutrition secondary to feed intolerance In
Change to feed formula type secondary to feed intolerance In
Change in weight (growth) between PICU admission and discharge In
Incidence of necrotizing enterocolitis In
Length of time IV In
Length of stay: PICU In
Mortality In
PP feeding (placing a PP tube) secondary to feed intolerance In
Administration of prokinetic drugs secondary to feed intolerance None
GI morbidity: Diarrhea None
Length of stay: Hospital None
Total length of time respiratory support (IV + NIV) None
Long-term feeding issues Out
Long-term outcomes (after hospital discharge) Out
Looking and/or behaving like their normal self Out
Nursing time spent measuring GRV Out
Change in length (growth) between PICU admission and discharge Out
Parental satisfaction Out
GI, gastrointestinal; GRV, gastric residual volume; IV, invasive ventilation; NIV, noninvasive ventilation; PICU, pediatric intensive care unit; PP,
postpyloric.
Table 5. Final 12 Outcomes Gaining Consensus for a Trial of
NO GRVMeasurement.
Time to achievement of predicted energy goals (full feeds)
Incidence of ventilator-acquired pneumonia
Duration of time with no enteral feed per 24 hours
Incidence of GI morbidity: Vomiting
Incidence of necrotizing enterocolitis
Length of time invasive ventilation
Length of stay: PICU
Mortality
Change in weight (growth) between PICU admission and
discharge
Administration of parenteral nutrition secondary to feed
intolerance
Change to feed formula type secondary to feed intolerance
PP feeding (placing a PP tube) secondary to feed
intolerance
GI, gastrointestinal; GRV, gastric residual volume; PICU, pediatric
intensive care unit; PP, postpyloric.
parents and clinicians for a future trial.5,18 It is also the first
to examine this in the context of a trial of no routine GRV
measurement to guide enteral feeding in pediatric critical
care. More recently, others have used this process in trials of
fluids and temperature control in pediatric critical care.5,18
The importance of choosing the most appropriate outcome
measures for a clinical trial is increasingly recognized.1
When trial outcomes are either not clinically relevant or
not considered important to parents/patients, the evidence
generated is less likely to be adopted and implemented into
clinical practice. This is costly and inefficient and leads to
research waste.19 Increasing efforts are being made to ro-
bustly identify and use the most appropriate trial outcomes
for all stakeholders, including patients and parents. To try
to overcome these issues, the development of standard-
ized core outcome sets (COSs) for patient populations is
encouraged.20 TheCoreOutcomeMeasures in Effectiveness
Trials (COMET) initiative aims to do this by developing and
agreeing on a set of outcomes known as a COS.20 These are
an agreedminimum set of outcomes that should be reported
in all trials of a specific disease or population.2
Of interest were the differences between clinical-
suggested and parent-suggested outcomes, especially
with respect to the longer-term issues after intensive care
discharge. Previous studies exploring prioritized outcomes
by parents5,18 have shown that parents who are interviewed
shortly after a child’s PICU admittance prioritized shorter-
term outcomes, which were potentially most relevant to
them at the time of being interviewed. However, parents
in this study were interviewed on average 11 months after
PICU discharge, and ongoing issues of importance to them
were more highly ranked as outcomes.
The final list of 12 agreed outcomes for a future trial
comprises nutrition outcomes (achievement of energy goals,
time spent without feeds, gastrointestinal morbidity, and
outcomes secondary to feed intolerance), adverse events
(VAP and necrotizing enterocolitis [NEC]), andmeasures of
morbidity (length of invasive ventilation and PICU length
of stay). Nutrition outcomes are clearly important in a trial
of any nutrition intervention, yet all previous adult trials
were powered on adverse events (VAP). Conversely, previous
neonatal trials, although measuring NEC (a condition far
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more common in preterm neonates), targeted nutrition
outcomes (time to achieve full enteral feeds) as the primary
outcome. Healthcare professionals are highly concerned
about adverse events21 and fear these potentially more than
they value improved outcomes in any new interventional
trial. However, the incidence of both VAP and NEC is
very low in pediatric critically ill children;22-24 therefore,
powering any trial based on these outcomes would require
such high numbers of eligible children to make a trial very
difficult. When we asked clinicians to choose their preferred
primary outcome measure, the nutrition outcomes of time
and the achievement of target energy goals were most
commonly selected. In pediatric critical care, the choice of
outcome for trials of nutrition interventions is important,
as mortality is too low to be feasibly used to power trials
(unlike adult critical care). In addition, nutrition outcomes
and their impact may be more important for children than
for adults, given that children need to grow (as well as
not lose weight) during critical illness. This becomes more
important as the length of time spent critically ill increases.
Currently, no COS exists for pediatric critical care or for
trials of nutrition interventions; however, adult work has
begun to generate a COS for adult critical care nutrition tri-
als. Future research to gain international consensus on core
outcomes and incorporate these standardized outcomes in
clinical nutrition and pediatric critical care trials is essential
and is planned in collaboration with professional societies.
Our study has several strengths. The approach taken
used a formalized approach and identified potential trial
outcomes from previous research and from parents with
experience of PICU care. In addition, the professionals
who attended the consensus meeting were not all the same
as those participating in the Delphi study, thus generating
a broader perspective, although there was some overlap.
However, there are also some limitations that warrant
mentioning. Some of the PICU parents also had experience
of neonatal care, which may have influenced their prior-
itization of longer-term outcomes and of the outcomes
themselves. The sample size for the Delphi was limited to
UK PICU professionals, specifically those with an interest
in research, and was small, which may limit the generaliz-
ability of these results to the wider group of PICU health
professionals. We targeted this group because this work
was to determine the feasibility of a UK trial within a
publicly funded healthcare system, and we therefore wanted
to involve and engage with UK PICU clinicians about a
future trial; there was, however, representation from the 3
main professional groups involved in enteral feeding. We
did not include parents in the Delphi survey, primarily
because we felt asking the parents at the interview was the
most appropriate way to gain meaningful input; however,
the lack of parent attendance at the consensus meeting
was a limitation and may have led to the final consensus
results being less representative of parent views. We utilized
all means to get parents to attend (and payment for their
time and travel was provided), but caring commitments
on the day prevented parents who had expressed interest
from attending the consensus meeting. Future work should
consider providing childcare to enable parents to attend.
Not having parents at this meeting is a limitation that
may have impacted on some parent-focused outcomes being
voted out. For the future trial, we will work further with our
expert parent group to ensure that outcomes of importance
to the parents are captured.
Conclusions
Given the increasing importance placed on determining the
optimal outcome measures for trials, this paper describes a
robust process to identify optimal outcomes for a future trial
of no routine GRV measurement to guide enteral feeding
in pediatric critical care. Using the most appropriate trial
outcomes increases the likelihood that future trial results
are both meaningful to parents/patients and implemented
in clinical practice.
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